SEC meets to consider Emergency Use Authorization request from Pfizer, SII and Bharat Biotech; to reconvene tomorrow

▴ SEC meets to consider Emergency Use Authorization request from Pfizer, SII and Bharat Biotech; to reconvene tomorrow
The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation, CDSCO met yesterday to consider Emergency Use Authorization request from Pfizer, SII, and Bharat Biotech Private Limited.

The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation, CDSCO met yesterday to consider the Emergency Use Authorisation request of Pfizer, Serum Institute of India (SII), and Bharat Biotech Private Limited.
 

Further time was requested on behalf of Pfizer. The additional data and information presented by SII and Bharat Biotech was perused and analysed by the SEC.

The analysis of the additional data and information is going on. The meeting of SEC will convene again tomorrow.

Tags : #IndiasCovidVaccineUpdates31Dec2020 #SubjectExportCommittee #CentralDrugsStandardControlOrganisation #Covid-19Vaccine #Vaccination #EmergencyUseAuthorisation #SII #BharatBiotech #Pfizer #MeetingforEmergencyUseofVaccine #DaliyCovid-19Updates

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Empowering India's Youth: IG Drones & AASSC Launch Drone Skill Program, to Upskill 10M YouthApril 17, 2024
Autonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 17, 2024
Top 5 online learning platform for learnersApril 17, 2024
Broad-Spectrum RNA Vaccine Breakthrough for Enhanced Virus ProtectionApril 17, 2024
The Impact of Excessive Internet Usage on School Absence: Finnish Study Reveals Key FindingsApril 17, 2024
Uncovering Delhi's Illegal Fertility Centre Operations: Insights from Recent Child Trafficking CasesApril 17, 2024
CarDekho's CSR Arm Girnar Foundation Hosts Health Check-up Camps for Underprivileged Children in Jaipur and GurugramApril 16, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 16, 2024
AVEKSHA, four-day care centres, for the kids of industrial workers inauguratedApril 16, 2024
Nearly a third of the constituencies have zero women candidates in Phase 1 and 2 of LS Elections; reveals The Quantum Hub’s Factsheet April 16, 2024
Emergency Healthcare Provider Medulance Secures $3 Million Series A Funding Led by Alkemi Growth CapitalApril 16, 2024
The Healing Power of Natural Diversity: How Nature Boosts Mental HealthApril 16, 2024
Unveiling Cellular Recycling: How Nutrient-Starved Cells Adapt to Stressful ConditionsApril 16, 2024
Advancing Cancer Care: AIIMS Bhopal’s Workshop on Biomarker Interpretation in Breast CancerApril 15, 2024
10 Powerful Benefits to Diversify Healthcare Advertising ChannelsApril 15, 2024
Understanding Hospital Sink Contamination: Challenges in Fighting Multidrug-Resistant BacteriaApril 15, 2024
Rajasthan’s Swine Flu Situation: Health Department Observes DeclineApril 15, 2024
Is Your Doctor’s Prescription Incomplete ? Insights from Recent ICMR Study Suggests So!April 13, 2024
Ministry of Health Dispels Misinformation on Medicine Price Surge from April 1April 13, 2024
India’s First Indigenous CAR T-Cell Therapy Launched By President Droupadi Murmu: A New Hope in Cancer TreatmentApril 12, 2024